Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 9.44
-0.16 (-1.72%)
At close: Sep 12, 2025
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of 833.50 million as of September 17, 2025. Its market cap has decreased by -25.66% in one year.
Market Cap
833.50M
Enterprise Value
595.97M
Revenue
230.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.44
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from 117.61M to 833.50M, an increase of 608.68%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 833.50M | -37.84% |
| Dec 31, 2024 | 1.34B | -5.49% |
| Dec 29, 2023 | 1.42B | 25.92% |
| Dec 30, 2022 | 1.13B | -9.61% |
| Dec 31, 2021 | 1.25B | 247.10% |
| Dec 31, 2020 | 359.09M | -0.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |